Methods of using adenosine receptor antagonists for treating bleeding disorders
AssigneeBayer HealthCare LLC
InventorDerek Sim
Life of this patent
Estimating the term…
Abstract
Methods of treating bleeding disorders, such as bleeding diseases such as hemophilia, by administering adenosine 2a receptor and/or adenosine 2b receptor antagonists to subjects in need thereof are disclosed. In some embodiments, the methods further include administration of the antagonist with one or more of Factor VIII, Factor IX and Factor XI to treat the bleeding disorder.
Claims22
A method for treating a bleeding disorder in a subject in need thereof, the method comprising administering a therapeutically effective amount of an adenosine receptor antagonist.
-18. (canceled)
A method for enhancing platelet aggregation in response to adenosine diphosphate (ADP) in a subject in need thereof, the method comprising administering a therapeutically effective amount of an adenosine receptor antagonist.
-28. (canceled)
A method for increasing platelet surface coagulation in a subject in need thereof, the method comprising administering a therapeutically effective amount of an adenosine receptor antagonist.
Dependencies are inferred from the claim text.